UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 3, 2021 (August 3, 2021)
HEALTHCARE TRUST OF AMERICA, INC.
HEALTHCARE TRUST OF AMERICA HOLDINGS, LP
(Exact name of registrant as specified in its charter) | | | | | | | | | | | | | | | | | | | | | | | |
| Maryland | (Healthcare Trust of America, Inc.) | | 001-35568 | | 20-4738467 | |
| Delaware | (Healthcare Trust of America Holdings, LP) | | 333-190916 | | 20-4738347 | |
| (State or other jurisdiction of incorporation or organization) | | (Commission File Number) | | (I.R.S. Employer Identification No.) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| 16435 N. Scottsdale Road, Suite 320, | Scottsdale, | Arizona | 85254 | | | | (480) | 998-3478 | | | |
| (Address of Principal Executive Office and Zip Code) | | | (Registrant’s telephone number, including area code) | | |
| | | | | | | |
| | |
| www.htareit.com |
| (Internet address) |
N/A
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | | | | | | | |
| Title of each class | | Trading symbol(s) | | Name of each exchange on which registered |
| Common stock, $0.01 par value | | HTA | | New York Stock Exchange |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: | | | | | |
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter): | | | | | | | | |
| Healthcare Trust of America, Inc. | ☐ | Emerging growth company |
| Healthcare Trust of America Holdings, LP | ☐ | Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | | | | | | | | | | | |
| Healthcare Trust of America, Inc. | ☐ | | |
| Healthcare Trust of America Holdings, LP | ☐ | | |
Healthcare Trust of America, Inc. (NYSE: HTA) (“HTA”) announced today that its Board of Directors has increased the quarterly dividend by 1.56% to $0.325 per share of common stock. This represents an annualized rate of $1.30 per share of common stock with an annualized yield of 4.6% based on HTA’s closing share price as of August 2, 2021. The dividend will be paid on October 11, 2021 to stockholders of record on October 4, 2021.
The amount of common stock dividends HTA pays to its stockholders is subject to the review and approval of HTA’s Board of Directors, at its discretion, and is dependent on a number of factors, including funds available for the payment of distributions, HTA’s financial condition, capital expenditure requirements and annual distribution requirements needed to maintain HTA’s status as a real estate investment trust under the Internal Revenue Code. HTA’s Board of Directors may reduce its dividend rate and HTA cannot guarantee the amount of dividends paid in the future, if any.
| | | | | |
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits. | | | | | |
| 99.1 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned hereunto duly authorized. | | | | | | | | | | | |
|
| | | |
| | Healthcare Trust of America, Inc. | |
| Date: August 3, 2021 | By: | /s/ Peter N. Foss | |
| | | Name: Peter N. Foss | |
| | | Title: Interim President and Chief Executive Officer | |
| | | | | | | | | | | |
| | Healthcare Trust of America Holdings, LP | |
| | | | |
| | By: | Healthcare Trust of America, Inc., | |
| | | its General Partner | |
| | | | |
| Date: August 3, 2021 | By: | /s/ Peter N. Foss | |
| | | Name: Peter N. Foss | |
| | | Title: Interim President and Chief Executive Officer | |
